How should the peripheral blood smear be interpreted in a patient with hairy cell leukemia who is negative for all common BRAF V600 (V600E, V600D, V600K, V600G, V600R) mutations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Interpretation of Peripheral Blood Smear in BRAF V600-Negative Hairy Cell Leukemia

This patient likely has hairy cell leukemia variant (HCL-V) or another HCL-like disorder rather than classic HCL, and the peripheral blood smear should be examined for specific morphologic features that distinguish these entities, with flow cytometry being essential for definitive characterization.

Critical Diagnostic Implications of BRAF V600 Negativity

The absence of all BRAF V600 mutations (E, D, K, G, R) is highly significant because BRAF V600E mutation is present in the overwhelming majority of classic HCL cases and is essentially absent in HCL-V 1. This negative result fundamentally changes the diagnostic approach and expected clinical behavior.

Key Morphologic Features to Assess on Peripheral Blood Smear

When examining the peripheral blood smear in this BRAF-negative case, specifically look for:

Classic HCL features (less likely given BRAF negativity):

  • Cells twice the size of normal lymphocytes
  • Round or kidney-shaped nuclei with loose chromatin
  • Abundant pale cytoplasm with fine projections
  • Monocytopenia (highly characteristic)
  • Macrocytosis

HCL-V features (more likely given BRAF negativity):

  • Prominent nucleoli (key distinguishing feature) 2
  • High lymphocyte counts (unlike classic HCL) 2
  • Cytoplasmic projections present but cells may be larger
  • Absence of monocytopenia 2
  • More aggressive appearance

Essential Flow Cytometry Correlation

The peripheral blood smear interpretation must be integrated with immunophenotyping results 1, 2:

Classic HCL immunophenotype:

  • CD19+, CD20+, CD11c+, CD25+, CD103+, CD123+, CD200+ (strong)

HCL-V immunophenotype (expected in BRAF-negative cases):

  • CD11c+ and often CD103+
  • CD25 negative or very weak (critical distinguishing feature) 2
  • CD123 variable or negative 2
  • FMC7+, CD20+, CD22+ present

Differential Diagnosis to Consider

Given BRAF V600 negativity, actively exclude:

  1. Hairy cell leukemia variant - most likely diagnosis
  2. Splenic marginal zone lymphoma (SMZL) - can have villous lymphocytes
  3. Splenic diffuse red pulp small B-cell lymphoma (SDRPL) - overlaps with HCL-V 2

Critical Clinical Pitfalls

Do not assume classic HCL behavior in BRAF-negative cases. HCL-V has:

  • Poor response to purine analogues (unlike classic HCL) 2
  • More aggressive clinical course
  • Different treatment requirements
  • Older age at presentation (median 71 years vs 53 years for classic HCL) 3

Rare Considerations

While uncommon, be aware that approximately 2% of HCL cases may have non-V600 BRAF mutations (F595L, W604L) or silent BRAF mutations 4. If clinical suspicion for classic HCL remains high despite negative V600 testing, consider:

  • Full BRAF gene sequencing
  • Bone marrow biopsy with immunohistochemistry for annexin A1 (positive in classic HCL, negative in HCL-V) 2
  • VE1 immunohistochemistry on bone marrow

Prognostic Implications

The absence of BRAF V600E mutation carries significant prognostic weight 1. Additionally, assess for:

  • TP53 mutations (adverse prognostic factor in both HCL and HCL-V) 2
  • IGHV mutational status (unmutated profile in 20% of cases associated with poor prognosis) 5
  • VH4-34 family usage (more frequent in HCL-V)

Recommended Diagnostic Algorithm

  1. Confirm morphology on peripheral blood smear focusing on nucleoli and monocyte count
  2. Complete flow cytometry with emphasis on CD25 and CD123 expression
  3. Bone marrow biopsy with immunohistochemistry (CD20, annexin A1, DBA.44) 1, 2
  4. Consider full BRAF sequencing if clinical picture suggests classic HCL 4
  5. Test for MAP2K1 mutations (found in HCL-V) 6

The treatment approach will differ substantially based on whether this is HCL-V versus classic HCL, as HCL-V responds poorly to standard purine analogue therapy and may require alternative strategies including clinical trial enrollment 2.

References

4
Research

Hairy cell leukaemia with unusual BRAF mutations.

Journal of cellular and molecular medicine, 2023

Related Questions

What is the characteristic bone marrow flow cytometry immunophenotype in classic hairy-cell leukemia?
Does a negative BRAF V600E mutation in her hairy‑cell leukemia suggest an exposure‑related cause?
If a patient is diagnosed with hairy cell leukemia but BRAF mutation analysis is negative, what does this indicate?
What bone marrow flow cytometry findings would indicate classic hairy cell leukemia versus hairy cell leukemia variant in a patient with BRAF‑V600E–negative mutations?
How should low hemoglobin and hematocrit be managed in a patient with hairy cell leukemia when transfusions do not raise the levels?
How should I manage a patient whose atomoxetine dose was increased from 40 mg to 80 mg daily while continuing citalopram and who is complaining of depressive symptoms?
What is the recommended surgical management for a patient with a recurrent labral tear who has persistent pain, mechanical symptoms, or instability despite adequate non‑operative therapy?
What are the most impactful microbiology and infectious diseases papers published in the past year that will influence clinical practice in the United Kingdom?
What topical antibiotic ointment is appropriate to prescribe for a superficial skin lesion in a patient without mupirocin allergy and who is not pregnant?
In a 20‑year‑old woman with major depressive disorder, anxiety, post‑traumatic stress disorder, and obsessive‑compulsive disorder who has been hospitalized 4–5 times for suicide attempts in one year, what factors are driving her repeated attempts—is it primarily her OCD or other underlying issues?
Interpret the provided CBC and iron studies and recommend appropriate management for the likely iron‑deficiency anemia.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.